Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 8, 2020 - The FDA announced the approval of Eli Lilly’s Retevmo (selpercatinib).
Return to publications